drugset / Trial / NCT01936350

Sildenafil Impact on Ventricular Function in Patients With Heart Failure

NCT01936350

Phase 2/3 Completed 24 enrolled Hospital Ana Nery
RandomizedParallel-groupTriple-blindTreatment

Summary

Twenty-four patients with known heart failure will be recruited. They will undergo a cardiac magnetic resonance for ventricular analyses and after this first exam they will be randomized to placebo or Sildenafil. After one hour drug intake they will undergo another cardiac magnetic resonance to evaluate the drug impact on right and left ventricular function.

Timeline

Start
2013-09
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg Oral

Indications